Pediatric Pharmacovigilance: Enhancing Adverse Drug Reaction Reporting in a Tertiary Care Children's Hospital

Therapeutic Innovation and Regulatory Science

Volumn 47, Issue 5, 2013, Pages 566-571

  Goldman, Jennifer L ^a   Sullins, Amanda ^a   Sandritter, Tracy ^a   Leeder, J Steven ^a   Lowry, Jennifer ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

adverse drug reactions; pediatrics; pharmacovigilance

Indexed keywords

ACCURACY; ARTICLE; CHILD; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HOSPITAL PERSONNEL; HUMAN; ICD-9; INCIDENT REPORT; MAJOR CLINICAL STUDY; MEDICAL DOCUMENTATION; MEDICAL EDUCATION; MEDICAL RECORD; PEDIATRIC HOSPITAL; PRIORITY JOURNAL; TERTIARY HEALTH CARE; UNITED STATES; VOLUNTARY REPORTING;

EID: 84883509421     PISSN: 21684790     EISSN: 21649200     Source Type: Journal    
DOI: 10.1177/2168479013499153     Document Type: Article

References (17)

1. World Health Organization. Medicines: safety of medicines-adverse drug reactions. Fact sheet no. 293. October 2008. Available at:http://www.who.int/mediacentre/factsheets/fs293/en/. Accessed June 6, 2013.
2. Impicciatore P,Choonara I,Clarkson A,Provasi D,Pandolfini C,Bonati M.Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies.Br J Clin Pharmacol. 2001;52 (1): 77-83.
3. Le J,Nguyen T,Law AV,Hodding J.Adverse drug reactions among children over a 10-year period.Pediatrics. 2006;118 (2): 555-562.
4. Weiss J,Krebs S,Hoffmann C, et al.Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection.Pediatrics. 2002;110 (2 Pt 1): 254-257.
5. Pirmohamed M,Breckenridge AM,Kitterignham NR,Park BK.Adverse drug reactions.BMJ. 1998;316 (7140): 1295-1298.
6. Riedl MA,Casillas AM.Adverse drug reactions: types and treatment options.Am Fam Physician. 2003;68 (9): 1781-1790.
7. Kessler DA.Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems.JAMA. 1993;269 (21): 2765-2768.
8. Naranjo CA,Busto U,Sellers EM, et al.A method for estimating the probability of adverse drug reactions.Clin Pharmacol Ther. 1981;30 (2): 239-245.
9. Belton KJ,Lewis SC,Payne S,Rawlins MD,Wood SM.Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom.Br J Clin Pharmacol. 1995;39 (3): 223-226.
10. Eland IA,Belton KJ,van Grootheest AC,Meiners AP,Rawlins MD,Stricker BH.Attitudinal survey of voluntary reporting of adverse drug reactions.Br J Clin Pharmacol. 1999;48 (4): 623-627.
11. Herdeiro MT,Figueiras A,Polónia J,Gestal-Otero JJ.Physicians' attitudes and adverse drug reaction reporting: a case-control study in Portugal.Drug Saf. 2005;28 (9): 825-833.
12. Azaz-Livshits T,Levy M,Sadan B,Shalit M,Geisslinger G,Brune K.Computerized survelliance of adverse drug reactions in hospital: pilot study.Br J Clin Pharmacol. 1998;45 (3): 309-314.
13. Evans RS,Pestotnik SL,Classen DC,Bass SB,Burke JP.Prevention of adverse drug events through computerized surveillance.Proc Annu Symp Comput Appl Med Care. 1992;:437-441.
14. Pushkin R,Frassetto L,Tsourounis C,Segal ES,Kim S.Improving the reporting of adverse drug reactions in the hospital setting.Postgrad Med. 2010;122 (6): 154-164.
15. Yoon D,Park MY,Choi NK,Park BJ,Kim JH,Park RW.Detection of adverse drug reaction signals using an electronic health records database: comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm.Clin Pharmacol Ther. 2012;91 (3): 467-474.
16. Figueiras A,Herdeiro MT,Polónia J,Gestal-Otero JJ.An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.JAMA. 2006;296 (9): 1086-1093.
17. Smyth RM,Gargon E,Kirkham J, et al.Adverse drug reactions in children: a systematic review.PLoS One. 2012;7 (3): e24061.